News
Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...
Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.
Oregon Health & Science University said a trained AI program can detect cancer of a larynx by picking up the distinct ...
An off-the-shelf cancer vaccine that targets KRAS mutations induced T-cell responses and was associated with impressive ...
Fox News senior medical analyst Dr. Marc Siegel discusses Health and Human Services Secretary Robert F. Kennedy Jr.
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.
A novel vaccine designed to target one of the most common cancer-driving mutations in patients with pancreatic and colorectal ...
Scientists have discovered the ability to “personalize” cancer treatments using cutting-edge genetic technology - but experts ...
A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...
New Phase I trial data finds that people who responded to ELI-002 survived longer and stayed cancer-free longer than usual.
A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results